Sanofi-Aventis U.S. LLC et al v. Apotex, Inc. et al > Summary
Court Case Number 1:16-cv-01312
Filing Date Dec 27, 2016
Court Delaware District Court
Status Unknown
Plaintiff Attorneys
14Sanofi
Attorney Name: Alison J. Baldwin
McDonnell Boehnen Hulbert & Berghoff LLP
Aventisub LLC
Attorney Name: Paul H. Berghoff
McDonnell Boehnen Hulbert & Berghoff LLP
Sanofi
Attorney Name: Paul H. Berghoff
McDonnell Boehnen Hulbert & Berghoff LLP
Aventisub LLC
Attorney Name: Jeffrey B. Bove
Buchanan Ingersoll & Rooney PC
Sanofi
Attorney Name: Jeffrey B. Bove
Buchanan Ingersoll & Rooney PC
Aventisub LLC
Attorney Name: Paula S. Fritsch
McDonnell Boehnen Hulbert & Berghoff LLP
Sanofi
Attorney Name: Paula S. Fritsch
McDonnell Boehnen Hulbert & Berghoff LLP
Aventisub LLC
Attorney Name: Brandon J. Kennedy
McDonnell Boehnen Hulbert & Berghoff LLP
Sanofi
Attorney Name: Brandon J. Kennedy
McDonnell Boehnen Hulbert & Berghoff LLP
Aventisub LLC
Attorney Name: Ann C. Palma
McDonnell Boehnen Hulbert & Berghoff LLP
Sanofi
Attorney Name: Ann C. Palma
McDonnell Boehnen Hulbert & Berghoff LLP
Aventisub LLC
Attorney Name: Karen Riesenburger Poppel
Buchanan Ingersoll & Rooney PC
Sanofi
Attorney Name: Karen Riesenburger Poppel
Buchanan Ingersoll & Rooney PC
Defendant Attorneys
2Apotex
Attorney Name: David A. Bilson
Phillips, McLaughlin & Hall, P.A.
Apotex
Attorney Name: John C. Phillips, Jr.
Phillips, McLaughlin & Hall, P.A.
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 09186346 | Methods for reducing the risk of an adverse teriflunomide and rosuvastatin interaction in multiple sclerosis patients | Nov 17, 2015 |
| 06794410 | Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4-trifluoromethylphenyl)-amide for treating multiple sclerosis | Sep 21, 2004 |
